KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) FCF Margin (2018 - 2025)

Historic FCF Margin for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to 69952.92%.

  • Vir Biotechnology's FCF Margin fell 626315700.0% to 69952.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 2728.46%, marking a year-over-year decrease of 21262000.0%. This contributed to the annual value of 611.35% for FY2024, which is 3173500.0% up from last year.
  • Vir Biotechnology's FCF Margin amounted to 69952.92% in Q3 2025, which was down 626315700.0% from 10111.78% recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's FCF Margin registered a high of 2312.48% during Q2 2022, and its lowest value of 69952.92% during Q3 2025.
  • In the last 5 years, Vir Biotechnology's FCF Margin had a median value of 652.06% in 2023 and averaged 5950.7%.
  • As far as peak fluctuations go, Vir Biotechnology's FCF Margin surged by 79472300bps in 2024, and later crashed by -626315700bps in 2025.
  • Vir Biotechnology's FCF Margin (Quarter) stood at 0.66% in 2021, then skyrocketed by 7005bps to 45.64% in 2022, then tumbled by -1529bps to 652.06% in 2023, then decreased by -11bps to 724.34% in 2024, then tumbled by -9557bps to 69952.92% in 2025.
  • Its last three reported values are 69952.92% in Q3 2025, 10111.78% for Q2 2025, and 2630.11% during Q1 2025.